<p>A: Quantification of iNOS. #: p = 0.017 vs. saline group 3 days after pMCAO; and δ: p = 0.004 vs. saline group 14 days after pMCAO. B: Quantification of CD11b. *: p = 0.021, #: p = 0.006 vs. saline group 3 days; and &: p = 0.003, δ: p = 0.002 vs. saline group 14 days after pMCAO. C: Quantification of CD206. *: p = 0.01 vs. saline group 3 days after pMCAO. D: Quantification of IL-10. *: p<0.001 vs. saline group on D3 after pMCAO.</p
<p>(A upper panel) Immunoblot analysis and (A lower panel) PP2A activity analysis for HT-29 CD133+ a...
<p>Expression of M1 & M2 markers relative to untreated healthy human peripheral blood MDM (U) in MDM...
<p>VK2/E6E7 cells were plated in the presence or absence of the indicated concentrations of MPA and ...
<p>A: Representative images of M1 (CD11b<sup>+</sup>Iba-1<sup>+</sup>) staining. The nuclei were cou...
<p>A: Quantification of SOD1. *: p = 0.009 vs. corresponding saline groups. B: Quantification of GPX...
<p>A: An image of cresyl violet-stained coronal section shows the areas used for cell-quantification...
<p>A: Representative images of cresyl violet-stained sections on D3 and D14 after pMCAO. Scale bar: ...
<p>(A) Upper: the effect of BAPTA-AM (20 µM) on iNOS expression in LPS (2 µg/mL)-stimulated macropha...
<p>Left panel <b>A</b> shows representative photomicrographs of anti-iNOS in red (a, e, i, m), DAPI ...
<p>A: expression of CD11b : the expression of CD11b increased after benzalkonium chloride (BAK) stim...
Univariate analysis of significantly altered metabolite changes after 5 or 15 min PMA treatment (FDR...
<p>(A and B) Cells were treated with (PMA) or without (w/o) 20 ng/ml PMA for 24 h. Subsequently, mRN...
(A) The levels of IL-6, TNF-a, IL-10, MCP-1, Arg-1, RELMa, Ym1, and iNOS mRNA in BMDMs stimulated wi...
<p>(A) Relative amount of iNOS protein expression after MB treatment. (B) Relative amount of iNOS pr...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>(A upper panel) Immunoblot analysis and (A lower panel) PP2A activity analysis for HT-29 CD133+ a...
<p>Expression of M1 & M2 markers relative to untreated healthy human peripheral blood MDM (U) in MDM...
<p>VK2/E6E7 cells were plated in the presence or absence of the indicated concentrations of MPA and ...
<p>A: Representative images of M1 (CD11b<sup>+</sup>Iba-1<sup>+</sup>) staining. The nuclei were cou...
<p>A: Quantification of SOD1. *: p = 0.009 vs. corresponding saline groups. B: Quantification of GPX...
<p>A: An image of cresyl violet-stained coronal section shows the areas used for cell-quantification...
<p>A: Representative images of cresyl violet-stained sections on D3 and D14 after pMCAO. Scale bar: ...
<p>(A) Upper: the effect of BAPTA-AM (20 µM) on iNOS expression in LPS (2 µg/mL)-stimulated macropha...
<p>Left panel <b>A</b> shows representative photomicrographs of anti-iNOS in red (a, e, i, m), DAPI ...
<p>A: expression of CD11b : the expression of CD11b increased after benzalkonium chloride (BAK) stim...
Univariate analysis of significantly altered metabolite changes after 5 or 15 min PMA treatment (FDR...
<p>(A and B) Cells were treated with (PMA) or without (w/o) 20 ng/ml PMA for 24 h. Subsequently, mRN...
(A) The levels of IL-6, TNF-a, IL-10, MCP-1, Arg-1, RELMa, Ym1, and iNOS mRNA in BMDMs stimulated wi...
<p>(A) Relative amount of iNOS protein expression after MB treatment. (B) Relative amount of iNOS pr...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>(A upper panel) Immunoblot analysis and (A lower panel) PP2A activity analysis for HT-29 CD133+ a...
<p>Expression of M1 & M2 markers relative to untreated healthy human peripheral blood MDM (U) in MDM...
<p>VK2/E6E7 cells were plated in the presence or absence of the indicated concentrations of MPA and ...